Researchers at the University of North Carolina at Chapel Hill hub of the international Structural Genomics Consortium will partner with the University of California, Davis to study the genes of rice plants responsible for root growth. The scientists will create … Continued

The Young Innovators Program, the Eshelman Institute of Innovation’s immersive research experiential program for high school students, has been awarded the Burroughs Wellcome Fund’s Student Science Enrichment Program Award of $180,000 over three years. The SSEP’s primary goal is to … Continued

The UNC Catalyst for Rare Diseases, together with Promega, sponsored an NIH/NCATS assay guidance workshop for high-throughput screening and lead discovery on Monday, October 23. Forty-nine scientists from academia and the pharmaceutical and biotechnology industries registered to attend. The workshop … Continued

Nate Hathaway, Ph.D., an assistant professor in the UNC Eshelman School of Pharmacy, has received a grant worth more than $1.5 million over five years from the National Institute of General Medical Sciences to investigate the mechanism of HP1-mediated heterochromatin … Continued

Strong molecular bonds between antibodies and biological gels like mucus aren’t necessary to catch pathogens as was previously thought, according to new research from the University of North Carolina at Chapel Hill. In fact, rapid and weak interactions between antibodies … Continued

Falcon Therapeutics, a company spun out of Assistant Professor Shawn’s Hingtgen’s work treating brain cancer, is one of the ventures contributing to a rise in the economic value of startups connected with the University of North Carolina at Chapel Hill, … Continued

The Structural Genomics Consortium at the University of North Carolina at Chapel Hill in partnership with the DiscoverX Corporation has reached the halfway point in developing a set of selective and potent inhibitors that will be made freely available to … Continued

A company founded by Rahima Benhabbour, Ph.D., a faculty member at the UNC Eshelman School of Pharmacy, has received a KickStart award from the University of North Carolina at Chapel Hill to help create the first 3-D printed intravaginal ring … Continued

Former health-care executive Kay Wagoner, Ph.D., has joined the Eshelman Institute for Innovation as associate director for innovation and entrepreneurship. Wagoner is also life science executive in residence in the UNC-Chapel Hill Office of Commercialization and Economic Development, an EIR … Continued

In a rapid-fire series of breakthroughs in just under a year, researchers at the UNC Eshelman School of Pharmacy have made another stunning advance in the development of an effective glioblastoma treatment for a common and aggressive brain cancer. The … Continued